CIK 0001850270
- Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- Operating
- EIN
- 981586514
- Phone
- +1 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Culleton Bruce Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +500,000 | 500,000 | ||
| 2026-03-01 | Culleton Bruce Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +3,000,000 | 3,000,000 | ||
| 2025-03-01 | Culleton Bruce Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +1,796,000 | 1,796,000 | ||
| 2024-09-13 | Culleton Bruce Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +500,000 | 500,000 | ||
| 2023-12-03 | Culleton Bruce Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +2,000,000 | 2,000,000 | ||
| 2023-08-01 | Culleton Bruce EVP, Clinical Development | Grant or award · Employee stock option (right to buy) | +485,000 | 485,000 |
Page 1 of 1 · 6 trades